List of Figures
Figure 1: Seasonal Influenza Vaccine Market, Top Seven Countries, Revenue Forecasts ($m), 2011–2018
Figure 2: Seasonal Influenza Vaccine Market, Top Seven Countries, Vaccination Coverage (%), 2011–2018
Figure 3: Seasonal Influenza Vaccine Market, Top Seven Countries, Population (‘000), 2011–2018
Figure 4: Seasonal Influenza Vaccine Market, Top Seven Countries, Vaccination Coverage by Age Group (%), 2011–2018
Figure 5: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Doses by Age Group (‘000), 2011–2018
Figure 6: Seasonal Influenza Vaccine Market, Top Seven Countries, Revenue Forecasts ($m), 2011–2018
Figure 7: Seasonal Influenza Vaccine Market, Top Seven Countries, Drivers and Restraints
Figure 8: Seasonal Influenza Vaccine Market, The US, Population (‘000), 2011–2018
Figure 9: Seasonal Influenza Vaccine Market, The US, Vaccination Coverage by Age Group (%), 2011–2018
Figure 10: Seasonal Influenza Vaccine Market, The US, Number of Doses by Age Group (‘000), 2011–2018
Figure 11: Seasonal Influenza Vaccine Market, The US, Revenue Forecasts ($m), 2011–2018
Figure 12: Seasonal Influenza Vaccine Market, The US, Drivers and Restraints
Figure 13: Seasonal Influenza Vaccine Market, The UK, Population (‘000), 2011–2018
Figure 14: Seasonal Influenza Vaccine Market, The UK, Vaccinated Coverage by Age Group (%), 2011–2018
Figure 15: Seasonal Influenza Vaccine Market, The UK, Number of Doses by Age Group (‘000), 2011–2018
Figure 16: Seasonal Influenza Vaccine Market, The UK, Revenue Forecasts ($m), 2011–2018
Figure 17: Seasonal Influenza Vaccine Market, The UK, Drivers and Restraints
Figure 18: Seasonal Influenza Vaccine Market, France, Population (‘000), 2011–2018
Figure 19: Seasonal Influenza Vaccine Market, France, Vaccination Coverage by Age Group (%), 2011–2018
Figure 20: Seasonal Influenza Vaccine Market, France, Number of Doses by Age Group (‘000), 2011–2018
Figure 21: Seasonal Influenza Vaccine Market, France, Revenue Forecasts ($m), 2011–2018
Figure 22: Seasonal Influenza Vaccine Market, France, Drivers and Restraints
Figure 23: Seasonal Influenza Vaccine Market, Italy, Population (‘000), 2011–2018
Figure 24: Seasonal Influenza Vaccine Market, Italy, Vaccination Coverage by Age Group (%), 2011–2018
Figure 25: Seasonal Influenza Vaccine Market, Italy, Number of Doses by Age Group (‘000), 2011–2018
Figure 26: Seasonal Influenza Vaccine Market, Italy, Revenue Forecasts ($m), 2011–2018
Figure 27: Seasonal Influenza Vaccine Market, Italy, Drivers and Restraints
Figure 28: Seasonal Influenza Vaccine Market, Spain, Population (‘000), 2011–2018
Figure 29: Seasonal Influenza Vaccine Market, Spain, Vaccination Coverage by Age Group (%), 2011–2018
Figure 30: Seasonal Influenza Vaccine Market, Spain, Number of Doses by Age Group (‘000), 2011–2018
Figure 31: Seasonal Influenza Vaccine Market, Spain, Revenue Forecasts ($m), 2011–2018
Figure 32: Seasonal Influenza Vaccine Market, Spain, Drivers and Restraints
Figure 33: Seasonal Influenza Vaccine Market, Germany, Population (‘000), 2011–2018
Figure 34: Seasonal Influenza Vaccine Market, Germany, Vaccination Coverage by Age Group (%), 2011–2018
Figure 35: Seasonal Influenza Vaccine Market, Germany, Number of Doses by Age Group (‘000), 2011–2018
Figure 36: Seasonal Influenza Vaccine Market, Germany, Revenue Forecasts ($m), 2011–2018
Figure 37: Seasonal Influenza Vaccine Market, Germany, Drivers and Restraints
Figure 38: Seasonal Influenza Vaccine Market, Japan, Population (‘000), 2011–2018
Figure 39: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage by Age Group (%), 2011–2018
Figure 40: Seasonal Influenza Vaccine Market, Japan, Number of Doses by Age Group (‘000), 2011–2018
Figure 41: Seasonal Influenza Vaccine Market, Japan, Revenue Forecasts ($m), 2011–2018
Figure 42: Seasonal Influenza Vaccine Market, Japan, Drivers and Restraints
Figure 43: Seasonal Influenza Vaccine Market, Regulatory Authorities, The US, 2012
Figure 44: Seasonal Influenza Vaccine Market, Drug Approval Process, The US, 2012
Figure 45: Seasonal Influenza Vaccine Market, Regulatory Authorities, EU, 2012
Figure 46: Seasonal Influenza Vaccine Market, Approval Process, EU, 2012
Figure 47: Seasonal Influenza Vaccine Market, Regulatory Authorities, Japan, 2012
Figure 48: Seasonal Influenza Vaccine Market, Drug Approval Process, Japan, 2012
Figure 49: Seasonal Influenza Vaccine Market, Top Seven Countries, R&D Pipeline by Phase (%), 2012
Figure 50: Seasonal Influenza Vaccine Market, Top Seven Countries, Market Share (%), 2011
Figure 51: Seasonal Influenza Vaccine Market, Top Seven Countries, Sanofi, SWOT Analysis
Figure 52: Seasonal Influenza Vaccine Market, Top Seven Countries, GSK, SWOT Analysis
Figure 53: Seasonal Influenza Vaccine Market, Top Seven Countries, Novartis, SWOT Analysis
Figure 54: Seasonal Influenza Vaccine Market, Top Seven Countries, AstraZeneca, SWOT Analysis
Figure 55: Seasonal Influenza Vaccine Market, Top Seven Countries, Deals by Type, 2009–2012
Figure 56: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Deals by Year, 2009–2012
Figure 57: Seasonal Influenza Vaccine Market, Top Seven Countries, M&A Deals by Geography, 2009–2012
Figure 58: Seasonal Influenza Vaccine Market, Top Seven Countries, M&A Deals by Year, 2009–2012
Figure 59: Seasonal Influenza Vaccine Market, Top Seven Countries, Licensing Agreements by Geography, 2009–2012
Figure 60: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Licensing Agreements by Year, 2009–2012
Figure 61: Seasonal Influenza Vaccine Market, Top Seven Countries, Partnership Deals by Geography, 2009–2012
Figure 62: Seasonal Influenza Vaccine Market, Top Seven Countries, Number of Partnership Deals by Year, 2009–2012
Figure 63: GBI Research Market Forecasting Model, Estimation of Market for a Country, 2010